Manufacturers Life Insurance Company, The Crispr Therapeutics Ag Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 12,477 shares of CRSP stock, worth $521,663. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,477
Previous 12,246
1.89%
Holding current value
$521,663
Previous $661,000
11.35%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CRSP
# of Institutions
487Shares Held
58MCall Options Held
1.09MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$331 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$314 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$125 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$124 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$116 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.26B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....